Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Autoimmune Disorders

Free Subscription Articles published in Mult Scler Retrieve available abstracts of 336 articles: HTML format Text format

Single Articles

March 2010
1. MASTORODEMOS V , Nikolakaki H, Tzagournissakis M, Kotzamani D, et al
   Benign multiple sclerosis in Crete*
   Mult Scler. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. TALLANTYRE EC , Bo L, Al-Rawashdeh O, Owens T, et al
   Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis.
   Mult Scler. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. BENTZEN J , Flachs EM, Stenager E, Bronnum-Hansen H, et al
   Prevalence of multiple sclerosis in Denmark 1950-2005.
   Mult Scler. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. GORGORAPTIS N , Wheeler-Kingshott CA, Jenkins TM, Altmann DR, et al
   Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis.
   Mult Scler. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. LARON M , Cheng H, Zhang B, Schiffman JS, et al
   Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.
   Mult Scler. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. GIJBELS D , Alders G, Van Hoof E, Charlier C, et al
   Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures.
   Mult Scler. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. GONSETTE RE , Sindic C, D'hooghe MB, De Deyn PP, et al
   Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon {beta} in relapsing-remitting Multiple Sclerosis (ASIIMS) trial.
   Mult Scler. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. DE STEFANO N , Curtin F, Stubinski B, Blevins G, et al
   Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis.
   Mult Scler. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. DALGAS U , Stenager E, Jakobsen J, Petersen T, et al
   Fatigue, mood and quality of life improve in MS patients after progressive resistance training.
   Mult Scler. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. HAWKES CH , Giovannoni G
    The McDonald Criteria for Multiple Sclerosis: time for clarification.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. DIAZ-SANCHEZ M , Gomez-Moreno SM, Morales-Otal MA, Ramos-Gonzalez A, et al
    Accuracy of MRI criteria for dissemination in space for the diagnosis of multiple sclerosis in patients with clinically isolated syndromes.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. STANKOVIC A , Dincic E, Ristic S, Lovrecic L, et al
    Interleukin 7 receptor alpha polymorphism rs6897932 and susceptibility to multiple sclerosis in the Western Balkans.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. POMEROY I , Jordan E, Frank J, Matthews P, et al
    Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. LAZZARINO G , Amorini A, Eikelenboom M, Killestein J, et al
    Cerebrospinal fluid ATP metabolites in multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. DELOIRE M , Ruet A, Hamel D, Bonnet M, et al
    Early cognitive impairment in multiple sclerosis predicts disability outcome several years later.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. KOUNTOURAS J , Gavalas E, Deretzi G, Boziki M, et al
    Helicobacter pylori with or without its neutrophil-activating protein may be the common denominator associated with multiple sclerosis and neuromyelitis optica.
    Mult Scler. 2010;16:376-7.
    PubMed     Text format     Related articles   
    
    
    
17. BERETICH BD , Beretich TM
    Authors' reply to 'Latitude and multiple sclerosis prevalence: vitamin D reduces risk of Epstein--Barr virus infection'.
    Mult Scler. 2010;16:374-5.
    PubMed     Text format     Related articles   
    
    
    
18. POORJAVAD M , Derakhshandeh F, Etemadifar M, Soleymani B, et al
    Oropharyngeal dysphagia in multiple sclerosis.
    Mult Scler. 2010;16:362-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. COMABELLA M , Montalban X, Horga A, Messmer B, et al
    Antiviral immune response in patients with multiple sclerosis and healthy siblings.
    Mult Scler. 2010;16:355-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. KHALEELI Z , Ciccarelli O, Mizskiel K, Altmann D, et al
    Lesion enhancement diminishes with time in primary progressive multiple sclerosis.
    Mult Scler. 2010;16:317-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. BLECHARZ KG , Haghikia A, Stasiolek M, Kruse N, et al
    Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis.
    Mult Scler. 2010;16:293-302.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2010
22. VASCONCELOS CC , Thuler LC, Dos Santos GA, Alvarenga MP, et al
    Differences in the progression of primary progressive multiple sclerosis in Brazilians of African descent versus white Brazilian patients.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. ZHAO Y , Petkau A, Traboulsee A, Riddehough A, et al
    Does MRI lesion activity regress in secondary progressive multiple sclerosis?
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. BERMEL R , Weinstock-Guttman B, Bourdette D, Foulds P, et al
    Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. FINK F , Eling P, Rischkau E, Beyer N, et al
    The association between California Verbal Learning Test performance and fibre impairment in multiple sclerosis: evidence from diffusion tensor imaging.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. KIRA JI , Minohara M, Li W, Matsushita T, et al
    Authors' reply to Helicobacter pylori with or without its neutrophil-activating protein may be the common denominator associated with multiple sclerosis and neuromyelitis optica.
    Mult Scler. 2010.
    PubMed     Text format     Related articles   
    
    
    
27. LANZILLO R , Orefice G, Quarantelli M, Rinaldi C, et al
    Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. QIU W , Bundell C, Wu JS, Castley A, et al
    Low level of systemic autoimmunity in Western Australian multiple sclerosis patients.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. PROSPERINI L , Leonardi L, De Carli P, Mannocchi ML, et al
    Visuo-proprioceptive training reduces risk of falls in patients with multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. INGRAM G , Colley E, Ben-Shlomo Y, Cossburn M, et al
    Validity of patient-derived disability and clinical data in multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. YADAV V , Marracci GH, Munar MY, Cherala G, et al
    Pharmacokinetic study of lipoic acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. OZTURK A , Smith S, Gordon-Lipkin E, Harrison D, et al
    MRI of the corpus callosum in multiple sclerosis: association with disability.
    Mult Scler. 2010;16:166-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
33. FORD C , Goodman AD, Johnson K, Kachuck N, et al
    Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis : results from the 15-year analysis of the US prospective open-label study of glatiramer acetate.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. SWANTON J , Fernando K, Dalton C, Miszkiel K, et al
    Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. SINCLAIR V , Shepard G
    Symptomatic, steroid-induced, multifocal diaphyseal osteonecrosis in a patient with multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. PAPADOPOULOS K , Tozer DJ, Fisniku L, Altmann DR, et al
    T1-relaxation time changes over five years in relapsing-remitting multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. WINSEN LM , Polman CH, Dijkstra CD, Tilders FJ, et al
    Suppressive effect of glucocorticoids on TNF-{alpha} production is associated with their clinical effect in multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. VOGT MH , Ten Kate J, Drent RJ, Polman CH, et al
    Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. MESAROS S , Rocca M, Sormani M, Valsasina P, et al
    Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. SOMER E , Golan D, Dishon S, Cuzin-Disegni L, et al
    Patients with multiple sclerosis in a war zone: coping strategies associated with reduced risk for relapse.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. MAGHZI A , Ghazavi H, Ahsan M, Etemadifar M, et al
    Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. FREEDMAN MS , Bar-Or A, Atkins HL, Karussis D, et al
    The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. WINSEN LM , Kragt JJ, Hoogervorst EL, Polman CH, et al
    Outcome measurement in multiple sclerosis: detection of clinically relevant improvement.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. SALZER J , Svenningsson A, Sundstrom P
    Neurofilament light as a prognostic marker in multiple sclerosis.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. REUB R , Schreiber V, Klein A, Infante-Duarte C, et al
    No significant effect of orally administered chemokine receptor 1 antagonist on intercellular adhesion molecule-3 expression in relapsing-remitting multiple sclerosis patients.
    Mult Scler. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. RAMAGOPALAN SV , Sadovnick AD, Ebers GC, Giovannoni G, et al
    Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.
    Mult Scler. 2010;16:127-8.
    PubMed     Text format     Related articles   
    
    
    
47. PELAYO R , Montalban X, Minoves T, Moncho D, et al
    Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?
    Mult Scler. 2010;16:55-61.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. GOTTESMAN MH , Friedman-Urevich S, Boylan E, Cheng D, et al
    Neutralizing antibodies to 500 microg interferon beta-1b: 28-month results of the IDEAS extension trial.
    Mult Scler. 2010;16:78-80.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. ADONI T , Lino AM, da Gama PD, Apostolos-Pereira SL, et al
    Recurrent neuromyelitis optica in Brazilian patients: clinical, immunological, and neuroimaging characteristics.
    Mult Scler. 2010;16:81-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
50. MEHTA LR , McDermott MP, Goodman AD, Schwid SR, et al
    A randomized trial of memantine as treatment for spasticity in multiple sclerosis.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. ISOBE N , Matsushita T, Yamasaki R, Ramagopalan S, et al
    Influence of HLA-DRB1 alleles on the susceptibility and resistance to multiple sclerosis in Japanese patients with respect to anti-aquaporin 4 antibody status.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. DRAKE A , Weinstock-Guttman B, Morrow S, Hojnacki D, et al
    Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol Digit Modalities Test.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. CALAIS G , Forzy G, Crinquette C, Mackowiak A, et al
    Tear analysis in clinically isolated syndrome as new multiple sclerosis criterion.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. GRANT WB
    Latitude and multiple sclerosis prevalence: vitamin D reduces risk of Epstein-Barr virus infection.
    Mult Scler. 2009.
    PubMed     Text format     Related articles   
    
    
    
55. COMI G , O'Connor P, Montalban X, Antel J, et al
    Phase II study of oral fingolimod (FTY720) in multiple sclerosis: 3-year results.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. PRINSTER A , Quarantelli M, Lanzillo R, Orefice G, et al
    A voxel-based morphometry study of disease severity correlates in relapsing-remitting multiple sclerosis.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. MENDOZZI L , Tronci F, Garegnani M, Pugnetti L, et al
    Sleep disturbance and fatigue in mild relapsing remitting multiple sclerosis patients on chronic immunomodulant therapy: an actigraphic study.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. HOHLFELD R
    'Gimme five': future challenges in multiple sclerosis. ECTRIMS Lecture 2009.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. SIMON KC , Munger KL, Yang X, Ascherio A, et al
    Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. MELLERGARD J , Edstrom M, Vrethem M, Ernerudh J, et al
    Natalizumab treatment in multiple sclerosis: Marked decline of chemokines and cytokines in cerebrospinal fluid.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
61. PFLEGER CC , Flachs EM, Koch-Henriksen N
    Social consequences of multiple sclerosis (1): early pension and temporary unemployment--a historical prospective cohort study.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. SPANO B , Cercignani M, Basile B, Romano S, et al
    Multiparametric MR investigation of the motor pyramidal system in patients with 'truly benign' multiple sclerosis.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. CHIARINI M , Sottini A, Ghidini C, Zanotti C, et al
    Renewal of the T-cell compartment in multiple sclerosis patients treated with glatiramer acetate.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. JENSEN MA , Yanowitch RN, Reder AT, White DM, et al
    Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon B-1b.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. RAMIL E , Sanchez AJ, Gonzalez-Perez P, Rodriguez-Antiguedad A, et al
    The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. FEINSTEIN A , O'Connor P, Akbar N, Moradzadeh L, et al
    Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. WU JS , Qiu W, Castley A, James I, et al
    Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. LONERGAN R , Kinsella K, Duggan M, Jordan S, et al
    Discontinuing disease-modifying therapy in progressive multiple sclerosis: can we stop what we have started?
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. ZELLINI F , Niepel G, Tench CR, Constantinescu CS, et al
    Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. PATTI F , Amato MP, Bastianello S, Caniatti L, et al
    Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. BRUM DG , Barreira AA, Santos AC, Kaimen-Maciel DR, et al
    HLA-DRB association in neuromyelitis optica is different from that observed in multiple sclerosis.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. REIBER H , Teut M, Pohl D, Rostasy KM, et al
    Paediatric and adult multiple sclerosis: age-related differences and time course of the neuroimmunological response in cerabrospinal fluid.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. MONTALBAN X , Sastre-Garriga J, Filippi M, Khaleeli Z, et al
    Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. URBANEK C , Weinges-Evers N, Bellmann-Strobl J, Bock M, et al
    Attention Network Test reveals alerting network dysfunction in multiple sclerosis.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. LARON M , Cheng H, Zhang B, Schiffman JS, et al
    Assessing visual pathway function in multiple sclerosis patients with multifocal visual evoked potentials.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. PENNER IK , Raselli C, Stocklin M, Opwis K, et al
    The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. ZIPOLI V , Goretti B, Hakiki B, Siracusa G, et al
    Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. BRUCE J , Hancock LM, Lynch SG
    Objective adherence monitoring in multiple sclerosis: initial validation and association with self-report.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. GIORDANO A , Messmer Uccelli M, Pucci E, Martinelli V, et al
    The Multiple Sclerosis Knowledge Questionnaire: a self-administered instrument for recently diagnosed patients.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. IDRIS MN , Sokrab TE, Ibrahim EA, Ali HE, et al
    Multiple sclerosis in Sudan: a prospective study of clinical presentation and outcome.
    Mult Scler. 2009;15:1537-8.
    PubMed     Text format     Related articles   
    
    
    
81. BERGAMASCHI R , Montomoli C
    Melanoma in multiple sclerosis treated with natalizumab: causal association or coincidence?
    Mult Scler. 2009;15:1532-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. MAWHINNEY E , Watt M, McDonnell GV
    Transient cardiomyopathy as the presenting feature of acute disseminated encephalomyelitis.
    Mult Scler. 2009;15:1534-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. GNEISS C , Koudouovoh-Tripp PM, Ropele S, Gotwald T, et al
    Influence of interferon-beta therapy switching on neutralizing antibody titres: results from the Austrian Switch Study.
    Mult Scler. 2009;15:1481-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
84. LI W , Minohara M, Piao H, Matsushita T, et al
    Association of anti-Helicobacter pylori neutrophil-activating protein antibody response with anti-aquaporin-4 autoimmunity in Japanese patients with multiple sclerosis and neuromyelitis optica.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. WU XM , Wang C, Zhang KN, Lin AY, et al
    Association of susceptibility to multiple sclerosis in Southern Han Chinese with HLA-DRB1, -DPB1 alleles and DRB1-DPB1 haplotypes: distinct from other populations.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. HONARMAND K , Feinstein A
    Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. PORTACCIO E , Goretti B, Zipoli V, Nacmias B, et al
    APOE-{varepsilon}4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. MACALLISTER WS , Christodoulou C, Troxell R, Milazzo M, et al
    Fatigue and Quality of Life in Pediatric Multiple Sclerosis.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. CECCARELLI A , Rocca MA, Neema M, Martinelli V, et al
    Deep gray matter T2 hypointensity is present in patients with clinically isolated syndromes suggestive of multiple sclerosis.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. DAHL OP , Stordal E, Lydersen S, Midgard R, et al
    Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trondelag County, Norway.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. WILKINS A , Ingram G, Brown A, Jardine P, et al
    Very long chain fatty acid levels in patients diagnosed with multiple sclerosis.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. NAKAMURA M , Houzen H, Niino M, Tanaka K, et al
    Relationship between Barkhof criteria and the clinical features of multiple sclerosis in northern Japan.
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. HOTERMANS C , Belachew S, Moonen G, Delwaide J, et al
    Severe liver dysfunction in a patient with multiple sclerosis: the guilty party is not always the disease-modifying therapy.
    Mult Scler. 2009;15:1378-9.
    PubMed     Text format     Related articles   
    
    
    
94. SOE SH , Kopsky DJ, Jongen PJ, de Vet HC, et al
    Multiple sclerosis patients with bladder dysfunction have decreased symptoms after electro-acupuncture.
    Mult Scler. 2009;15:1376-7.
    PubMed     Text format     Related articles   
    
    
    
95. BENESOVA Y
    Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
    Mult Scler. 2009;15:1374-5.
    PubMed     Text format     Related articles   
    
    
    
96. VEUGELERS PJ , Fisk JD, Brown MG, Stadnyk K, et al
    Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation.
    Mult Scler. 2009;15:1286-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. JUNG K
    Consideration of preanalytical impact of blood sampling on measurement of matrix metalloproteinases and their inhibitors as precondition to evaluate their relationship to clinical data.
    Mult Scler. 2009;15:1372-3.
    PubMed     Text format     Related articles   
    
    
    
98. CUTTER G
    Evidence of treatment benefit: is seeing believing or obfuscation by statistics?
    Mult Scler. 2009;15:1251-2.
    PubMed     Text format     Related articles   
    
    
    October 2009
99. WAYNE MOORE GR , Vitali AM, Leung E, Laule C, et al
    Thalamic stimulation in multiple sclerosis: evidence for a 'demyelinative thalamotomy'?
    Mult Scler. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. HUGHES CM , Smyth S, Lowe-Strong AS
     Reflexology for the treatment of pain in people with multiple sclerosis: a double-blind randomised sham-controlled clinical trial.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. YAMOUT B , Usta J, Itani S, Yaghi S, et al
     Celiac disease, Behcet, and idiopathic thrombocytopenic purpura in siblings of a patient with multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. PASCUAL AM , Tellez N, Bosca I, Mallada J, et al
     Revision of the risk of secondary leukemia after mitoxantrone in multiple sclerosis populations is required.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. RINALDI F , Perini P, Calabrese M, Rinaldi L, et al
     Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. CORDELLA R , Franzini A, La Mantia L, Marras C, et al
     Hypothalamic stimulation for trigeminal neuralgia in multiple sclerosis patients: efficacy on the paroxysmal ophthalmic pain.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. SMESTAD C , Sandvik L, Celius EG
     Excess mortality and cause of death in a cohort of Norwegian multiple sclerosis patients.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. HOLMOY T , Moen SM, Gundersen TA, Holick MF, et al
     25-Hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. FREEDMAN MS
     "Time is brain" also in multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles   
     
     
     
108. BOSTROM I , Callander M, Kurtzke JF, Landtblom AM, et al
     High prevalence of multiple sclerosis in the Swedish county of Varmland.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. FESTA ED , Hankiewicz K, Kim S, Skurnick J, et al
     Serum levels of CXCL13 are elevated in active multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. RIVERA-NAVARRO J , Benito-Leon J, Oreja-Guevara C, Pardo J, et al
     Burden and health-related quality of life of Spanish caregivers of persons with multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. CASETTA I , Riise T, Nortvedt MW, Economou NT, et al
     Gender differences in health-related quality of life in multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. DE ABREU DA , Babron MC, Rebeix C, Fontenille J, et al
     Season of birth and not vitamin D receptor promoter polymorphisms is a risk factor for multiple sclerosis.
     Mult Scler. 2009;15:1146-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. GARCEA O , Villa A, Caceres F, Adoni T, et al
     Early treatment of multiple sclerosis: a Latin American experts meeting.
     Mult Scler. 2009;15 Suppl 3:S1-S12.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2009
114. NEUTEBOOM RF , Verbraak E, Voerman JS, van Meurs M, et al
     First trimester interleukin 8 levels are associated with postpartum relapse in multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. MONTALBAN X , Sastre-Garriga J, Tintore M, Brieva L, et al
     A single-centre, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. BIELEKOVA B , Richert N, Howard T, Packer AN, et al
     Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood-brain barrier disruption in multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. METZ LM , Li D, Traboulsee A, Myles ML, et al
     Glatiramer Acetate in Combination with Minocycline in Patients with Relapsing-Remitting Multiple Sclerosis: Results of a Canadian, Multicenter, Double-Blind, Placebo-Controlled Trial.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. GOODIN DS , Bates D
     Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. WESSON JM , Cooper JA, Jehle LS, Lockhart SN, et al
     The functional index for living with multiple sclerosis: development and validation of a new quality of life questionnaire.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. ETEMADIFAR M , Fatehi F, Sahraian M, Borhanihaghighi A, et al
     Multiple sclerosis and neurofibromatosis type 1: report of seven patients from Iran.
     Mult Scler. 2009;15:1126-30.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. WEBER-SCHOENDORFER C , Schaefer C
     Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study.
     Mult Scler. 2009;15:1037-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. PODBIELSKA M , Hogan E
     Molecular and immunogenic features of myelin lipids: incitants or modulators of multiple sclerosis?
     Mult Scler. 2009;15:1011-29.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. 
     Abstracts of the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis. September 9-12, 2009. Dusseldorf, Germany.
     Mult Scler. 2009;15 Suppl 2:S5-277.
     PubMed     Text format     Related articles   
     
     
     
124. 
     Abstract of Multiple Sclerosis 2009.
     Mult Scler. 2009;15.
     PubMed     Text format     Related articles   
     
     
     August 2009
125. HAMILTON F , Rochester L, Paul L, Rafferty D, et al
     Walking and talking: an investigation of cognitive-motor dual tasking in multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. TIEMANN L , Penner I, Haupts M, Schlegel U, et al
     Cognitive decline in multiple sclerosis: impact of topographic lesion distribution on differential cognitive deficit patterns.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
127. MELANSON M , Miao P, Eisenstat D, Gong Y, et al
     Experimental autoimmune encephalomyelitis-induced upregulation of tumor necrosis factor-alpha in the dorsal root ganglia.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. MORROW S , Weinstock-Guttman B, Munschauer F, Hojnacki D, et al
     Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: cross-sectional and longitudinal analysis.
     Mult Scler. 2009;15:998-1005.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. RUDICK R , Polman C, Cohen J, Walton M, et al
     Assessing disability progression with the Multiple Sclerosis Functional Composite.
     Mult Scler. 2009;15:984-997.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. BAR-OR A , Oger J, Gibbs E, Niino M, et al
     Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?
     Mult Scler. 2009;15:959-64.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. CALABRESE M , Gallo P
     Magnetic resonance evidence of cortical onset of multiple sclerosis.
     Mult Scler. 2009;15:933-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. SIVA A , Saip S, Altintas A, Jacob A, et al
     Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease.
     Mult Scler. 2009;15:918-27.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. NEUTEBOOM R , Verbraak E, Voerman J, van Meurs M, et al
     Serum leptin levels during pregnancy in multiple sclerosis.
     Mult Scler. 2009;15:907-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. PEDOTTI R , Farinotti M, Falcone C, Borgonovo L, et al
     Allergy and multiple sclerosis: a population-based case-control study.
     Mult Scler. 2009;15:899-906.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. BERETICH B , Beretich T
     Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis.
     Mult Scler. 2009;15:891-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. EBERS G
     Editorial regarding "Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis," by Beretich and Beretich.
     Mult Scler. 2009;15:889-90.
     PubMed     Text format     Related articles   
     
     
     
137. PELLKOFER HL , Suessmair C, Schulze A, Hohlfeld R, et al
     Course of neuromyelitis optica during inadvertent pregnancy in a patient treated with rituximab.
     Mult Scler. 2009;15:1006-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. CENIT MD , Blanco-Kelly F, de las Heras V, Bartolome M, et al
     Glypican 5 is an interferon-beta response gene: a replication study.
     Mult Scler. 2009;15:913-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. MILLONIG A , Rudzki D, Holzl M, Ehling R, et al
     High-dose intravenous interferon beta in patients with neutralizing antibodies (HINABS): a pilot study.
     Mult Scler. 2009;15:977-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2009
140. CHANSON J , Kremer S, Blanc F, Marescaux C, et al
     Foreign accent syndrome as a first sign of multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. COCCO E , Sardu C, Murru R, Frau J, et al
     Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. HEESEN C , Schaffler N, Kasper J, Muhlhauser I, et al
     Suspected multiple sclerosis - what to do? Evaluation of a patient information leaflet.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. RADZISZEWSKI P , Crayton R, Zaborski J, Czlonkowska A, et al
     Multiple sclerosis produces significant changes in urinary bladder innervation which are partially reflected in the lower urinary tract functional status-sensory nerve fibers role in detrusor overactivity.
     Mult Scler. 2009;15:860-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. VALENTINO P , Cerasa A, Chiriaco C, Nistico R, et al
     Cognitive deficits in multiple sclerosis patients with cerebellar symptoms.
     Mult Scler. 2009;15:854-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. PATTI F , Amato M, Trojano M, Bastianello S, et al
     Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
     Mult Scler. 2009;15:779-788.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. BENEDICT R
     Standards for sample composition and impairment classification in neuropsychological studies of multiple sclerosis.
     Mult Scler. 2009;15:777-8.
     PubMed     Text format     Related articles   
     
     
     
147. GLAD S , Nyland H, Aarseth J, Riise T, et al
     Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. BONZANO L , Roccatagliata L, Mancardi G, Sormani M, et al
     Gadolinium-enhancing or active T2 magnetic resonance imaging lesions in multiple sclerosis clinical trials?
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. CHONG HT , Kira J, Tsai CP, Ong B, et al
     Proposed modifications to the McDonald criteria for use in Asia.
     Mult Scler. 2009;15:887-8.
     PubMed     Text format     Related articles   
     
     
     
150. RIO J , Castillo J, Rovira A, Tintore M, et al
     Measures in the first year of therapy predict the response to interferon beta in MS.
     Mult Scler. 2009;15:848-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. CABRERA-GOMEZ JA , Bonnan M, Gonzalez-Quevedo A, Saiz-Hinarejos A, et al
     Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies.
     Mult Scler. 2009;15:828-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. YEH EA , Weinstock-Guttman B, Lincoff N, Reynolds J, et al
     Retinal nerve fiber thickness in inflammatory demyelinating diseases of childhood onset.
     Mult Scler. 2009;15:802-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2009
153. KHALIL M , Enzinger C, Langkammer C, Tscherner M, et al
     Quantitative assessment of brain iron by R2* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. DOWARD L , McKenna S, Meads D, Twiss J, et al
     The development of patient-reported outcome indices for multiple sclerosis (PRIMUS).
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. UKKONEN M , Vahvelainen T, Hamalainen P, Dastidar P, et al
     Cognitive dysfunction in primary progressive multiple sclerosis: a neuropsychological and MRI study.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. CREANGE A , Debouverie M, Jaillon-Riviere V, Taithe F, et al
     Home administration of intravenous methylprednisolone for multiple sclerosis relapses: the experience of French multiple sclerosis networks.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. STROBER L , Englert J, Munschauer F, Weinstock-Guttman B, et al
     Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. KLISTORNER A , Arvind H, Nguyen T, Garrick R, et al
     Fellow eye changes in optic neuritis correlate with the risk of multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. SILVA A , Bettencourt A, Pereira C, Santos E, et al
     Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.
     Mult Scler. 2009;15:771-4.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. STELMASIAK Z , Solski J, Nowicki J, Jakubowska B, et al
     Effect of parenteral cladribine on relapse rates in patients with relapsing forms of multiple sclerosis: results of a 2-year, double-blind, placebo-controlled, crossover study.
     Mult Scler. 2009;15:767-70.
     PubMed     Text format     Related articles    Abstract available
     
     
     
161. GANESVARAN G , Greer J, Pender M
     Prominent brainstem and cerebellar involvement in multiple sclerosis with psoriasis.
     Mult Scler. 2009;15:763-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. KERN S , Schrempf W, Schneider H, Schultheiss T, et al
     Neurological disability, psychological distress, and health-related quality of life in MS patients within the first three years after diagnosis.
     Mult Scler. 2009;15:752-758.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. HOLST B , Siemonsen S, Finsterbusch J, Bester M, et al
     T2' imaging indicates decreased tissue metabolism in frontal white matter of MS patients.
     Mult Scler. 2009;15:701-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. CECCARELLI A , Filippi M, Neema M, Arora A, et al
     T2 hypointensity in the deep gray matter of patients with benign multiple sclerosis.
     Mult Scler. 2009;15:678-86.
     PubMed     Text format     Related articles    Abstract available
     
     
     
165. O'CONNOR P , Kinkel RP, Kremenchutzky M
     Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria.
     Mult Scler. 2009;15:728-34.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. HAWKES CH , Macgregor AJ
     Twin studies and the heritability of MS: a conclusion.
     Mult Scler. 2009;15:661-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
167. NAKAMURA M , Misu T, Fujihara K, Miyazawa I, et al
     Occurrence of acute large and edematous callosal lesions in neuromyelitis optica.
     Mult Scler. 2009;15:695-700.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. ROOSENDAAL SD , Moraal B, Pouwels PJ, Vrenken H, et al
     Accumulation of cortical lesions in MS: relation with cognitive impairment.
     Mult Scler. 2009;15:708-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2009
169. LEDINEK A , Jazbec S, Drinovec I, Rot U, et al
     Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case report.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
170. MATSUSHITA T , Isobe N, Matsuoka T, Shi N, et al
     Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. BENEDETTI B , Rovaris M, Rocca M, Caputo D, et al
     In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. ANDERSON V , Fisniku L, Altmann D, Thompson A, et al
     MRI measures show significant cerebellar gray matter volume loss in multiple sclerosis and are associated with cerebellar dysfunction.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
173. AL-IZKI S , Pryce G, Giovannoni G, Baker D, et al
     Evaluating potential therapies for bladder dysfunction in a mouse model of multiple sclerosis with high-resolution ultrasonography.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
174. CARROLL W
     Clinical trials of multiple sclerosis therapies: improvements to demonstrate long-term patient benefit.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. KHAN F , Turner-Stokes L, Stevermuer T, Simmonds F, et al
     Multiple sclerosis rehabilitation outcomes: analysis of a national casemix data set from Australia.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. ANDREASEN A , Jakobsen J, Petersen T, Andersen H, et al
     Fatigued patients with multiple sclerosis have impaired central muscle activation.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. HAVRDOVA E , Zivadinov R, Krasensky J, Dwyer M, et al
     Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
178. CHENG Q , Cheng XJ, Jiang GX
     Multiple sclerosis in China--history and future.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. HON G , Hassan M, van Rensburg S, Abel S, et al
     Erythrocyte membrane fatty acids in patients with multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. FISNIKU L , Altmann D, Cercignani M, Tozer D, et al
     Magnetization transfer ratio abnormalities reflect clinically relevant grey matter damage in multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
181. FURBY J , Hayton T, Altmann D, Brenner R, et al
     Different white matter lesion characteristics correlate with distinct grey matter abnormalities on magnetic resonance imaging in secondary progressive multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
182. MARRIE R , Horwitz R, Cutter G, Tyry T, et al
     Measuring up rates for adverse health behaviors in multiple sclerosis: the need for action.
     Mult Scler. 2009;15:648.
     PubMed     Text format     Related articles   
     
     
     
183. LIANG J , Zhang H, Hua B, Wang H, et al
     Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis.
     Mult Scler. 2009;15:644-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
184. GARDENER H , Munger K, Chitnis T, Spiegelman D, et al
     The relationship between handedness and risk of multiple sclerosis.
     Mult Scler. 2009;15:587-92.
     PubMed     Text format     Related articles    Abstract available
     
     
     
185. MEHTA L , Schwid S, Arnold D, Cutter G, et al
     Proof of concept studies for tissue-protective agents in multiple sclerosis.
     Mult Scler. 2009;15:542-546.
     PubMed     Text format     Related articles    Abstract available
     
     
     
186. SATOH J , Tabunoki H, Yamamura T
     Molecular network of the comprehensive multiple sclerosis brain-lesion proteome.
     Mult Scler. 2009;15:531-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
187. HAN M , Steinman L
     Systems biology for identification of molecular networks in multiple sclerosis.
     Mult Scler. 2009;15:529-30.
     PubMed     Text format     Related articles   
     
     
     
188. BROWN TR
     Measuring up rates for adverse health behaviors in MS.
     Mult Scler. 2009;15:647.
     PubMed     Text format     Related articles   
     
     
     
189. MINNEBOO A , Uitdehaag BM, Jongen P, Vrenken H, et al
     Association between MRI parameters and the MS severity scale: a 12 year follow-up study.
     Mult Scler. 2009;15:632-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
190. BICHUETTI DB , Oliveira EM, Souza NA, Rivero RL, et al
     Neuromyelitis optica in Brazil: a study on clinical and prognostic factors.
     Mult Scler. 2009;15:613-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
191. ZEPHIR H , Fajardy I, Outteryck O, Blanc F, et al
     Is neuromyelitis optica associated with human leukocyte antigen?
     Mult Scler. 2009;15:571-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     April 2009
192. DICKINSON J , Perera D, van der Mei A, Ponsonby AL, et al
     Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
193. BOSMA L , Kragt J, Brieva L, Khaleeli Z, et al
     The search for responsive clinical endpoints in primary progressive multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
194. KOBELT G , Texier-Richard B, Lindgren P
     The long-term cost of multiple sclerosis in France and potential changes with disease-modifying interventions.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
195. HIREMATH G , Cettomai D, Baynes M, Ratchford J, et al
     Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
196. BERNAL F , Elias B, Hartung H, Kieseier B, et al
     Regulation of matrix metalloproteinases and their inhibitors by interferon-{beta}: a longitudinal study in multiple sclerosis patients.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
197. HAARTSEN J , Marriott M, Butzkueven H
     Re: Early relapses after the first dose of natalizumab in active multiple sclerosis.
     Mult Scler. 2009;15:520.
     PubMed     Text format     Related articles   
     
     
     
198. RITHIDECH K , Honikel L, Milazzo M, Madigan D, et al
     Protein expression profiles in pediatric multiple sclerosis: potential biomarkers.
     Mult Scler. 2009;15:455-64.
     PubMed     Text format     Related articles    Abstract available
     
     
     
199. FREEDMAN M , Laks J, Dotan N, Altstock R, et al
     Anti-{alpha}-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event.
     Mult Scler. 2009;15:422-30.
     PubMed     Text format     Related articles    Abstract available
     
     
     
200. ASANO M , Dawes Dj, Arafah A, Moriello C, et al
     What does a structured review of the effectiveness of exercise interventions for persons with multiple sclerosis tell us about the challenges of designing trials?
     Mult Scler. 2009;15:412-21.
     PubMed     Text format     Related articles    Abstract available
     
     
     
201. TINTORE M , Sastre-Garriga J
     Role of MRI criteria and OB for diagnosing multiple sclerosis in patients presenting with clinically isolated syndromes.
     Mult Scler. 2009;15:407-8.
     PubMed     Text format     Related articles   
     
     
     
202. MEHTA L , Rose J
     Recurrent granuloma annulare during treatment with daclizumab.
     Mult Scler. 2009;15:527-8.
     PubMed     Text format     Related articles   
     
     
     
203. KILLESTEIN J , Jasperse B, Liedorp M, Seewann A, et al
     Very late delayed-allergic reaction to natalizumab not associated with neutralizing antibodies.
     Mult Scler. 2009;15:525-6.
     PubMed     Text format     Related articles   
     
     
     
204. FLOHIL M , Verheul G, Schuuring J
     Is it a relapse?
     Mult Scler. 2009;15:523-4.
     PubMed     Text format     Related articles   
     
     
     
205. BONNAN M , Valentino R, Olindo S, Mehdaoui H, et al
     Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder.
     Mult Scler. 2009;15:487-92.
     PubMed     Text format     Related articles    Abstract available
     
     
     
206. MAYO N , Asano M
     Not another meta-analysis!
     Mult Scler. 2009;15:409-11.
     PubMed     Text format     Related articles   
     
     
     
207. ELLIS R , Boggild M
     Therapy-related acute leukaemia with Mitoxantrone: what is the risk and can we minimise it?
     Mult Scler. 2009;15:505-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
208. KNEIDER M , Bergstrom T, Gustafsson C, Nenonen N, et al
     Sequence analysis of human rhinovirus aspirated from the nasopharynx of patients with relapsing-remitting MS.
     Mult Scler. 2009;15:437-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
209. SALTER AR , Conger A, Frohman TC, Zivadinov R, et al
     Retinal architecture predicts pupillary reflex metrics in MS.
     Mult Scler. 2009;15:479-86.
     PubMed     Text format     Related articles    Abstract available
     
     
     
210. HASHIMOTO S , Ball Nj, Tremlett H
     Progressive lipoatrophy after cessation of glatiramer acetate injections: a case report.
     Mult Scler. 2009;15:521-2.
     PubMed     Text format     Related articles   
     
     
     March 2009
211. PORTACCIO E , Goretti B, Lori S, Zipoli V, et al
     The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
212. CHEN Y , Lin H, Lin H
     Does multiple sclerosis increase risk of adverse pregnancy outcomes? A population-based study.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
213. FAINARDI E , Castellazzi M, Tamborino C, Trentini A, et al
     Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
214. WHITE A , Lee J, Light A, Light K, et al
     Brain activation in multiple sclerosis: a BOLD fMRI study of the effects of fatiguing hand exercise.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
215. CHITNIS T , Glanz B, Jaffin S, Healy B, et al
     Demographics of pediatric-onset multiple sclerosis in an MS center population from the Northeastern United States.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
216. KOCH-HENRIKSEN N , Sorensen P, Bendtzen K, Flachs E, et al
     The clinical effect of neutralizing antibodies against interferon-beta is independent of the type of interferon-beta used for patients with relapsing-remitting multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
217. LODE K , Bru E, Klevan G, Myhr K, et al
     Depressive symptoms and coping in newly diagnosed patients with multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
218. FERNANDEZ LIGUORI N , Klajn D, Acion L, Caceres F, et al
     Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study).
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
219. ZEPHIR H , Lefranc D, Dubucquoi S, de Seze J, et al
     Serum IgG repertoire in clinically isolated syndrome predicts multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
220. BARRETT C , Mann G, Taylor P, Strike P, et al
     A randomized trial to investigate the effects of functional electrical stimulation and therapeutic exercise on walking performance for people with multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
221. ARRONDO G , Alegre M, Sepulcre J, Iriarte J, et al
     Abnormalities in brain synchronization are correlated with cognitive impairment in multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
222. STICH O , Janowitz D, Rauer S
     Spontaneous intracerebral hemorrhage in a patient with multiple sclerosis and tumefactive demyelinating lesion.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
223. PORTACCIO E , Zipoli V, Goretti B, De Stefano N, et al
     Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.
     Mult Scler. 2009;15:403.
     PubMed     Text format     Related articles   
     
     
     
224. JULIAN L , Vella L, Frankel D, Minden S, et al
     ApoE alleles, depression and positive affect in multiple sclerosis.
     Mult Scler. 2009;15:311-315.
     PubMed     Text format     Related articles    Abstract available
     
     
     
225. GRAY O , Abdeen H, McDonnell G, Patterson C, et al
     An investigation of susceptibility loci in benign, aggressive and primary progressive multiple sclerosis in Northern Irish population.
     Mult Scler. 2009;15:299-303.
     PubMed     Text format     Related articles    Abstract available
     
     
     
226. FAZEKAS F , Thompson A
     New MRI techniques and "aggressive" multiple sclerosis.
     Mult Scler. 2009;15:283-4.
     PubMed     Text format     Related articles   
     
     
     
227. PICHIECCHIO A , Tavazzi E, Maccabelli G, Precupanu CM, et al
     What insights have new imaging techniques given into aggressive forms of MS--different forms of MS or different from MS?
     Mult Scler. 2009;15:285-93.
     PubMed     Text format     Related articles    Abstract available
     
     
     
228. ANTULOV R , Weinstock-Guttman B, Cox JL, Hussein S, et al
     Gender-related differences in MS: a study of conventional and nonconventional MRI measures.
     Mult Scler. 2009;15:345-54.
     PubMed     Text format     Related articles    Abstract available
     
     
     
229. DOI H , Matsushita T, Isobe N, Matsuoka T, et al
     Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody.
     Mult Scler. 2009;15:304-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
230. SARESELLA M , Rolland A, Marventano I, Cavarretta R, et al
     Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
231. PATRICK E , Christodoulou C, Krupp L
     Longitudinal correlates of fatigue in multiple sclerosis.
     Mult Scler. 2009;15:258-261.
     PubMed     Text format     Related articles    Abstract available
     
     
     
232. DEBOUVERIE M , Laforest L, Van Ganse E, Guillemin F, et al
     Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients.
     Mult Scler. 2009;15:251-257.
     PubMed     Text format     Related articles    Abstract available
     
     
     
233. MALHOTRA HS , Jain KK, Agarwal A, Singh MK, et al
     Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.
     Mult Scler. 2009;15:193-203.
     PubMed     Text format     Related articles    Abstract available
     
     
     
234. FAGIUS J , Lundgren J, Oberg G
     Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation.
     Mult Scler. 2009;15:229-37.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
235. FEYS P , D'hooghe M, Nagels G, Helsen W, et al
     The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
236. BOGOSIAN A , Moss-Morris R, Yardley L, Dennison L, et al
     Experiences of partners of people in the early stages of multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
237. MARRIE R , Horwitz R, Cutter G, Tyry T, et al
     The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
238. RICO A , Audoin B, Franques J, Eusebio A, et al
     Motor evoked potentials in clinically isolated syndrome suggestive of multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
239. NIELSEN T , Rostgaard K, Askling J, Steffensen R, et al
     Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
240. BENESOVA Y , Vasku A, Novotna H, Litzman J, et al
     Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
241. MATTSSON N , Axelsson M, Haghighi S, Malmestrom C, et al
     Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
242. ZIPOLI V , Hakiki B, Portaccio E, Lolli F, et al
     The contribution of cerebrospinal fluid oligoclonal bands to the early diagnosis of multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
243. KAWAJIRI M , Mogi M, Higaki N, Matsuoka T, et al
     Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
244. ALI E , Healy B, Stazzone L, Brown B, et al
     Daclizumab in treatment of multiple sclerosis patients.
     Mult Scler. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
245. ANTEL J , Carroll W, Thompson A
     Reflections on 2008.
     Mult Scler. 2009;15:1.
     PubMed     Text format     Related articles   
     
     
     
246. SUTTON I , Lahoria R, Tan I, Clouston P, et al
     CNS demyelination and quadrivalent HPV vaccination.
     Mult Scler. 2009;15:116-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
247. FILIPPI M , Calabrese M, Gallo P
     Response letter regarding the article "Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study," by Calabrese, et al.
     Mult Scler. 2008.
     PubMed     Text format     Related articles   
     
     
     
248. KORTEWEG T , Rovaris M, Neacsu V, Filippi M, et al
     Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
249. ALIX J
     Axons and multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles   
     
     
     
250. BROADLEY S , Vanags D, Williams B, Johnson B, et al
     Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
251. PODER K , Ghatavi K, Fisk J, Campbell T, et al
     Social anxiety in a multiple sclerosis clinic population.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
252. RAVNBORG M , Bendtzen K, Christensen O, Jensen P, et al
     Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
253. SAWAYA R , Kanso M
     Multiple sclerosis in Lebanon: a review of 45 cases.
     Mult Scler. 2008.
     PubMed     Text format     Related articles   
     
     
     
254. PFLEGER C , Koch-Henriksen N, Stenager E, Flachs E, et al
     Head injury is not a risk factor for multiple sclerosis: a prospective cohort study.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
255. VAHTER L , Zopp I, Kreegipuu M, Kool P, et al
     Clean intermittent self-catheterization in persons with multiple sclerosis: the influence of cognitive dysfunction.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
256. SEPULCRE J , Masdeu J, Goni J, Arrondo G, et al
     Fatigue in multiple sclerosis is associated with the disruption of frontal and parietal pathways.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
257. OSOEGAWA M , Kira J, Fukazawa T, Fujihara K, et al
     Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
258. ATZORI M , Battistella P, Perini P, Calabrese M, et al
     Clinical and diagnostic aspects of multiple sclerosis and acute monophasic encephalomyelitis in pediatric patients: a single centre prospective study.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
259. TEDESCHI G , Dinacci D, Comerci M, Lavorgna L, et al
     Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
260. DE STEFANO N , Filippi M, Confavreux C, Vermersch P, et al
     The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
261. NELSON F , Poonawalla A, Hou P, Wolinsky J, et al
     3D MPRAGE improves classification of cortical lesions in multiple sclerosis.
     Mult Scler. 2008;14:1214-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
262. MATSUOKA T , Matsushita T, Osoegawa M, Kawano Y, et al
     Association of the HLA-DRB1 alleles with characteristic MRI features of Asian multiple sclerosis.
     Mult Scler. 2008;14:1181-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
263. MAYO N
     Setting the agenda for multiple sclerosis rehabilitation research.
     Mult Scler. 2008;14:1154-1156.
     PubMed     Text format     Related articles   
     
     
     
264. ANTEL J , Carroll W, Thompson A
     Differential diagnosis of initial isolated clinical presentations.
     Mult Scler. 2008;14:1153.
     PubMed     Text format     Related articles   
     
     
     
265. BROCHET B , Deloire MS, Bonnet M, Salort-Campana E, et al
     Should SDMT substitute for PASAT in MSFC? A 5-year longitudinal study.
     Mult Scler. 2008;14:1242-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
266. NICOLETTI A , Patti F, Lo Fermo S, Messina S, et al
     A possible spatial and temporal cluster of multiple sclerosis in the town of Linguaglossa, Sicily: an update.
     Mult Scler. 2008.
     PubMed     Text format     Related articles   
     
     
     
267. PETEREIT H , Rubbert-Roth A
     Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
268. RAUSCH M , Tofts P, Lervik P, Walmsley A, et al
     Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f*
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
269. MONTIEL-NAVA C , Pena J, Gonzalez-Pernia S, Mora-La Cruz E, et al
     Cognitive functioning in children with multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
270. CABRERA-GOMEZ J , Ramon-Perez L, Saiz A, Llerena-Fernandez P, et al
     Neuromyelitis optica and multiple sclerosis in sisters.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
271. GAJOFATTO A , Bacchetti P, Grimes B, High A, et al
     Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
272. JAMROZ-WISNIEWSKA A , Beltowski J, Stelmasiak Z, Bartosik-Psujek H, et al
     Paraoxonase 1 activity in different types of multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
273. GILMORE C , Geurts J, Evangelou N, Bot J, et al
     Spinal cord grey matter lesions in multiple sclerosis detected by post-mortem high field MR imaging.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
274. KOPKE S , Kasper J, Muhlhauser I, Nubling M, et al
     Patient education program to enhance decision autonomy in multiple sclerosis relapse management: a randomized-controlled trial.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
275. LINDSEY J , Hatfield L, Crawford M, Patel S, et al
     Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
276. VAN DEN ELSKAMP I , Knol D, Uitdehaag B, Barkhof F, et al
     The distribution of new enhancing lesion counts in multiple sclerosis: further explorations.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
277. CATTANEO D , Jonsdottir J
     Sensory impairments in quiet standing in subjects with multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
278. VANOTTI S , Benedict R, Acion L, Caceres F, et al
     Validation of the Multiple Sclerosis Neuropsychological Screening Questionnaire in Argentina.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
279. VALENTINO P , Labate A, Nistico R, Pirritano D, et al
     Anti-GM1 antibodies are not associated with cerebral atrophy in patients with multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
280. MARRIE R , Horwitz R, Cutter G, Tyry T, et al
     High frequency of adverse health behaviors in multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
281. GRAY O , McDonnell G, Hawkins S
     Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2008
282. RAMAGOPALAN S , Dyment D, Ebers G
     Autoimmune disease in patients with multiple sclerosis and their first-degree relatives: a nationwide cohort study in Denmark.
     Mult Scler. 2008.
     PubMed     Text format     Related articles   
     
     
     
283. PATTI F
     Cognitive impairment in multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
284. IACOBAEUS E , Ryschkewitsch C, Gravell M, Khademi M, et al
     Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
285. MILLER D , Weinshenker B, Filippi M, Banwell B, et al
     Differential diagnosis of suspected multiple sclerosis: a consensus approach.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
286. KOUTSIS G , Panas M, Giogkaraki E, Karadima G, et al
     An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
287. VAN DER VOORT L , Kok A, Visser A, Oudejans C, et al
     Interferon-{beta} bioactivity measurement in multiple sclerosis: feasibility for routine clinical practice.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
288. NOCITI V , Bentivoglio AR, Frisullo G, Fasano A, et al
     Movement disorders in multiple sclerosis: causal or coincidental association?
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
289. CONFAVREUX C , Ritleng C, Debouverie M, Durand-Dubief F, et al
     Defining the natural history of multiple sclerosis: the need for complete data and rigorous definitions. Answer to Dr Tremlett et al.
     Mult Scler. 2008;14:1144-1147.
     PubMed     Text format     Related articles   
     
     
     
290. MARRIE R , Horwitz R, Cutter G, Tyry T, et al
     Comorbidity, socioeconomic status and multiple sclerosis.
     Mult Scler. 2008;14:1091-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
291. FIGVED N , Benedict R, Klevan G, Myhr K, et al
     Relationship of cognitive impairment to psychiatric symptoms in multiple sclerosis.
     Mult Scler. 2008;14:1084-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
292. GIRONI M , Martinelli-Boneschi F, Sacerdote P, Solaro C, et al
     A pilot trial of low-dose naltrexone in primary progressive multiple sclerosis.
     Mult Scler. 2008;14:1076-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
293. KURTZKE J
     Some contributions of the Department of Veterans Affairs to the epidemiology of multiple sclerosis.
     Mult Scler. 2008;14:1007-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
294. 
     Abstracts of the World Congress on Treatment and Research in Multiple Sclerosis, September 17-20, 2008, Montreal, Canada.
     Mult Scler. 2008;14 Suppl 1:S1-314.
     PubMed     Text format     Related articles   
     
     
     
295. ARIAS M , Osorio X, Dapena D, Arias-Rivas S, et al
     Recurrent leukoencephalopathy with microhemorrhages: gradient-echo MRI study diagnostic value in CNS primary angiitis.
     Mult Scler. 2008;14:1139-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     
296. TREMLETT H , Zhao Y, Devonshire V
     Defining the natural history of MS: the need for complete data and rigorous definitions.
     Mult Scler. 2008;14:1142-3.
     PubMed     Text format     Related articles   
     
     
     
297. WEINSTOCK-GUTTMAN B , Miller C, Yeh E, Stosic M, et al
     Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica.
     Mult Scler. 2008;14:1061-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
298. POTAGAS C , Mitsonis C, Watier L, Dellatolas G, et al
     Influence of anxiety and reported stressful life events on relapses in multiple sclerosis: a prospective study.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
299. MILLS RJ , Young CA, Nicholas RS, Pallant JF, et al
     Rasch analysis of the Fatigue Severity Scale in multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
300. CALABRESE M , Filippi M, Rovaris M, Bernardi V, et al
     Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
301. OTAEGUI D , Zuriarrain O, Castillo-Trivino T, Aransay AM, et al
     Association between synapsin III gene promoter SNPs and multiple sclerosis in Basque patients.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
302. THANGARAJH M , Gomez-Rial J, Hedstrom AK, Hillert J, et al
     Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
303. SHI N , Kawano Y, Matsuoka T, Mei FJ, et al
     Increase of CD4+TNF{alpha}+IL-2-T cells in cerebrospinal fluid of multiple sclerosis patients.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
304. GIOVANNONI G , Barbarash O, Casset-Semanaz F, King J, et al
     Safety and immunogenicity of a new formulation of interferon {beta}-1a (Rebif(R) New Formulation) in a Phase IIIb study in patients with relapsing multiple sclerosis: 96-week results.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
305. TAI AK , O'Reilly EJ, Alroy KA, Simon KC, et al
     Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
306. FOX RJ , Kivisakk P, Fisher E, Tucky B, et al
     Multiple sclerosis: chemokine receptor expression on circulating lymphocytes in correlation with radiographic measures of tissue injury.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
307. CENTONZE D , Furlan R, Gasperini C, Salvetti M, et al
     Early relapses after the first dose of natalizumab in active multiple sclerosis patients.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
308. KRAGT JJ , van Amerongen BM, Killestein J, Dijkstra CD, et al
     Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
309. PRAKASH RS , Snook EM, Lewis JM, Motl RW, et al
     Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
310. JOHANSSON S , Ytterberg C, Gottberg K, Widen Holmqvist L, et al
     Use of health services in people with multiple sclerosis with and without fatigue.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
311. NIKLAS A , Sebraoui H, Hess E, Wagner A, et al
     Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
312. COCCO E , Sardu C, Gallo P, Capra R, et al
     Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
313. INVERNIZZI P , Bonometti MA, Turri E, Benedetti MD, et al
     A case of Fabry disease with central nervous system (CNS) demyelinating lesions: a double trouble?
     Mult Scler. 2008;14:1003-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
314. COSTELLO F , Hodge W, Pan YI, Eggenberger E, et al
     Tracking retinal nerve fiber layer loss after optic neuritis: a prospective study using optical coherence tomography.
     Mult Scler. 2008;14:893-905.
     PubMed     Text format     Related articles    Abstract available
     
     
     
315. NIELSEN JM , Uitdehaag BM, Polman CH
     Long-term follow-up of suspected though unconfirmed MS.
     Mult Scler. 2008;14:985-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
316. NILSSON P , Rorsman I, Larsson EM, Norrving B, et al
     Cognitive dysfunction 24-31 years after isolated optic neuritis.
     Mult Scler. 2008;14:913-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
317. DUQUE B , Sepulcre J, Bejarano B, Samaranch L, et al
     Memory decline evolves independently of disease activity in MS.
     Mult Scler. 2008;14:947-53.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2008
318. SANNA A , Huang YM, Arru G, Fois ML, et al
     Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
319. MAMUTSE G , Woolmore J, Pye E, Partridge J, et al
     Vitamin D receptor gene polymorphism is associated with reduced disability in multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
320. VAZIRINEJAD R , Lilley J, Ward C
     A health profile of adults with multiple sclerosis living in the community.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
321. SMOLDERS J , Menheere P, Kessels A, Damoiseaux J, et al
     Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
322. BECKERMAN H , van Zee IE, de Groot V, van den Bos GA, et al
     Utilization of health care by patients with multiple sclerosis is based on professional and patient-defined health needs.
     Mult Scler. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
323. ROVARIS M , Judica E, Ceccarelli A, Ghezzi A, et al
     Absence of diffuse cervical cord tissue damage in early, non-disabling relapsing-remitting MS: a preliminary study.
     Mult Scler. 2008;14:853-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
324. GNEISS C , Brugger M, Millonig A, Fogdell-Hahn A, et al
     Comparative study of four different assays for the detection of binding antibodies against interferon-beta.
     Mult Scler. 2008;14:830-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
325. MOREH E , Gartsman I, Karussis D, Rund D, et al
     Seronegative neuromyelitis optica: improvement following lymphocytapheresis treatment.
     Mult Scler. 2008;14:860-1.
     PubMed     Text format     Related articles   
     
     
     
326. SORENSEN PS , Koch-Henriksen N, Flachs EM, Bendtzen K, et al
     Is the treatment effect of IFN-beta restored after the disappearance of neutralizing antibodies?
     Mult Scler. 2008;14:837-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2008
327. KOBELT G , Berg J, Lindgren P, Jonsson B, et al
     Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared with current standard practice in Sweden.
     Mult Scler. 2008;14:679-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2008
328. TZORTZIS V , Skriapas K, Hadjigeorgiou G, Mitsogiannis I, et al
     Sexual dysfunction in newly diagnosed multiple sclerosis women.
     Mult Scler. 2008;14:561-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
329. CARDINAL KS , Wilson SM, Giesser BS, Drain AE, et al
     A longitudinal fMRI study of the paced auditory serial addition task.
     Mult Scler. 2008;14:465-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
330. MARIGNIER R , De Seze J, Vukusic S, Durand-Dubief F, et al
     NMO-IgG and Devic's neuromyelitis optica: a French experience.
     Mult Scler. 2008;14:440-5.
     PubMed     Text format     Related articles    Abstract available
     
     
     
331. SIMO M , Barsi P, Aranyi Z
     Predictive role of evoked potential examinations in patients with clinically isolated optic neuritis in light of the revised McDonald criteria.
     Mult Scler. 2008;14:472-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     April 2008
332. CONFAVREUX C
     Defining the natural history of MS: the need for complete data and rigorous definitions.
     Mult Scler. 2008;14:289-91.
     PubMed     Text format     Related articles   
     
     
     
333. FUVESI J , Bencsik K, Benedek K, Matyas K, et al
     Cross-cultural adaptation and validation of the 'Multiple Sclerosis Quality of Life Instrument' in Hungarian.
     Mult Scler. 2008;14:391-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
334. GRABNER R , Popotnig F, Ropele S, Neuper C, et al
     Brain activation patterns elicited by the 'Faces Symbol Test' -- a pilot fMRI study.
     Mult Scler. 2008;14:354-63.
     PubMed     Text format     Related articles    Abstract available
     
     
     
335. KOCH M , Uyttenboogaart M, Heerings M, Heersema D, et al
     Progression in familial and nonfamilial MS.
     Mult Scler. 2008;14:300-6.
     PubMed     Text format     Related articles    Abstract available
     
     
     
336. COHEN JA , Calabresi PA, Chakraborty S, Edwards KR, et al
     Avonex Combination Trial in relapsing--remitting MS: rationale, design and baseline data.
     Mult Scler. 2008;14:370-82.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: